How melanoma resists BRAF inhibitors by Angus Liu Wednesday, November 7, 2018 A phosphor-binding site on aberrantly spliced BRAF V600E could become a new target against drug-resistant melanoma.
Unraveling the mysteries of drug resistance in melanoma by Arlene Weintraub Friday, August 24, 2018 Researchers used the gene editing system CRISPR-Cas9 to discover a signature of resistance to BRAF inhibitors in melanoma.
